CellAegis Devices, Inc. Receives Marketing Authorization
Mar 7, 2013March 7, 2013: CellAegis Devices, Inc., announced today that it has received marketing authorization from Health Canada that allows for the commercial introduction in Canada of the Company’s autoRIC™ Device for Remote Ischemic Conditioning (RIC). Health Canada has granted a Medical Device Class III license for use of the autoRIC Device to provide non-invasive RIC for adult patients undergoing cardiothoracic surgery or interventional cardiothoracic procedures, as well as for patients with evolving myocardial infarction.